Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism EphA2 modulators(Ephrin type-A receptor 2 modulators), NKp46 modulators(Natural cytotoxicity triggering receptor 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 30 Sep 2022 |